skip to Main Content

EQ-5D-5L | Valuation

A standardized valuation study protocol (called EQ-VT) was developed by the EuroQol Group to create standard value sets for the EQ-5D-5L. This protocol is based on the use of the composite time trade-off (cTTO) valuation technique, supplemented by a discrete choice experiment (DCE). We recommend EQ-5D-5L users to use the standard value sets, as these were produced with the EuroQol Group’s standardised valuation technology EQ-VT.

A list of all currently available standard value sets for the EQ-5D-5L can be found in the table below (Last updated on 26JUL2021).

Click here for an overview of EQ-5D-5L valuation studies that are ongoing or completed.

If a value set for your preferred adult EQ-5D version (5L or 3L) is not available for your country/region but a value set for a different EQ-5D version is available, then a “crosswalk” mapping function can be used to derive utility values. The mapping function links EQ-5D descriptive system responses to the available value set.

EuroQol researchers have developed crosswalk functions to:

The Van Hout (2012, 2021) crosswalks are based on international datasets, with mapping between response options, and can therefore be implemented with any EQ-5D value set.

Please note that in the UK, as an interim measure whilst a new UK EQ-5D-5L value set is being developed, a different mapping function is recommended for use in submissions to NICE (see EQ-5D-5L valuation webpage) for more information.

Overview of available standard value sets for EQ-5D-5L  –  [ BACK TO OVERVIEW ]

(*) NICE does not recommend using this 5L value set for England for NICE technology appraisal submissions. EuroQol, in partnership with NICE, the Department of Health and Social Care and NHS England is currently developing a new EQ-5D-5L value set for the UK.

(Version 26JUL2021)

Back To Top
Search